Bio-Path Holdings, Inc. (BPTH)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.55-0.01 (-0.64%)
At close: 4:00 PM EDT
People also watch:
BLFSADMPCASIBSPMATOS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open1.53
Prev Close1.56
Bid1.19 x 100
Ask1.75 x 300
Day's Range1.53 - 1.58
52wk Range1.00 - 3.19
1y Target EstN/A
Market Cap148.25M
P/E Ratio (ttm)-20.67
Beta3.52
Volume57,208
Avg Vol (3m)367,236
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • GlobeNewswire21 days ago

    Bio-Path Holdings Reports Second Quarter 2016 Financial Results

    HOUSTON, Aug. 10, 2016-- Bio-Path Holdings, Inc., a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid ...

  • Associated Press21 days ago

    Bio-Path reports 2Q loss

    The Bellaire, Texas-based company said it had a loss of 2 cents per share. The company's shares closed at $1.73. A year ago, they were trading at $1.21. _____ This story was generated by Automated Insights ...

  • GlobeNewswire28 days ago

    Bio-Path Holdings to Announce Second Quarter 2016 Financial Results on August 10, 2016

    HOUSTON, Aug. 03, 2016-- Bio-Path Holdings, Inc.,, a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid ...